Literature DB >> 29661650

Community-acquired methicillin-resistant Staphylococcus aureus can persist in the throat.

Aida Hamdan-Partida1, Samuel González-García1, Estela de la Rosa García1, Jaime Bustos-Martínez2.   

Abstract

Colonization by Staphylococcus aureus is an important factor in infections caused by this microorganism. Among the colonization niches of staphylococci are the nose, skin, intestinal tract, and, recently, the throat has been given relevance. Infections caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) can be fatal. Persistence of S. aureus is an important process in the pathogenesis of this microorganism and must be studied. The aim of this study was to determine the persistence of S. aureus in the throat, and characterized the strains. We studied the persistence of S. aureus for 6 years in the throat of apparently healthy people. The isolated strains from the persistent carriers were characterized through PFGE, spa-typing, SCCmec typing, resistance to methicillin, presence of virulence genes (adhesins and toxins), and the formation of biofilm. We found persistent and intermittent carriers of S. aureus in the throat, with methicillin-sensitive (MSSA), methicillin-resistant (MRSA) strains, and confirmed for the first time that CA-MRSA colonizes this niche. These strains can colonize persistently the throat for four years or more. Typification of strains through PFGE and spa-typing revealed that some carriers present the same strain, whereas others present different strains along the period of persistence. Almost all strains induced a strong biofilm formation. All strains presented adhesin and toxin genes, but no shared genotype was found. We conclude that S. aureus, including CA-MRSA strains, can remain persistently in the throat, finding a wide variability among the persistent strains.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  CA-MRSA; Persistence; Staphylococcus aureus; Throat; Virulence genes

Mesh:

Substances:

Year:  2018        PMID: 29661650     DOI: 10.1016/j.ijmm.2018.04.002

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  6 in total

1.  Investigation of Virulence Genes of Staphylococcus aureus Isolated from Sterile Body Fluid Samples and Their Correlation with Clinical Symptoms and Outcomes.

Authors:  Tao Lin; Qianhui Li; Defu Jin; Wanbo Liu; Chaogui Tang; Xiaoyun Zhang
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-12-26       Impact factor: 2.471

2.  Methicillin-Resistant Staphylococcus aureus Nasal Colonization Among Health Care Workers of a Tertiary Hospital in Ecuador and Associated Risk Factors.

Authors:  Isabel Baroja; Sara Guerra; Marco Coral-Almeida; Alejandra Ruíz; Juan Miguel Galarza; Jacobus H de Waard; Carlos Bastidas-Caldes
Journal:  Infect Drug Resist       Date:  2021-08-25       Impact factor: 4.003

Review 3.  Exebacase: A Novel Approach to the Treatment of Staphylococcal Infections.

Authors:  Matthew W McCarthy
Journal:  Drugs R D       Date:  2022-02-17

4.  Absence of methicillin-resistant Staphylococcus aureus colonization among immunocompetent healthy adults: Insights from a longitudinal study.

Authors:  Sónia T Almeida; A Cristina Paulo; João Babo; João Borralho; Catarina Figueiredo; Bruno Gonçalves; João Lança; Mónica Louro; Hermes Morais; Joana Queiroz; Hermínia de Lencastre; Raquel Sá-Leão
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

5.  Molecular Characterization of Staphylococcus aureus Strains Isolated from Mobile Phones.

Authors:  Aída Hamdan-Partida; Samuel González-García; Francisco Javier Martínez-Ruíz; Miguel Ángel Zavala-Sánchez; Anaíd Bustos-Hamdan; Jaime Bustos-Martínez
Journal:  Microorganisms       Date:  2022-03-21

6.  Temporal and spatial dynamics in the apple flower microbiome in the presence of the phytopathogen Erwinia amylovora.

Authors:  Zhouqi Cui; Regan B Huntley; Quan Zeng; Blaire Steven
Journal:  ISME J       Date:  2020-10-06       Impact factor: 10.302

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.